“Development of Benzothiazole-Based Inhibitors of Mitochondrial Enzyme 17β-HSD10: Potential Treatment for Alzheimer’s Disease and Other Pathologies”

https://pubmed.ncbi.nlm.nih.gov/38116418

A new series of benzothiazole-based inhibitors of the mitochondrial enzyme 17β-HSD10 with nanomolar potency and low cytotoxicity have been developed, demonstrating potential for the treatment of Alzheimer’s disease and other pathologies.